BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 129 filers reported holding BIOSCRIP INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,242,000 | +130.0% | 539,914 | +100.0% | 0.24% | +18.3% |
| Q1 2019 | $540,000 | -24.4% | 269,957 | +35.0% | 0.20% | -26.0% |
| Q4 2018 | $714,000 | -70.4% | 200,000 | -69.9% | 0.27% | -36.5% |
| Q2 2015 | $2,414,000 | -18.2% | 665,000 | -0.2% | 0.43% | -17.5% |
| Q1 2015 | $2,950,000 | -31.9% | 666,000 | +7.5% | 0.52% | -34.2% |
| Q4 2014 | $4,329,000 | +7.6% | 619,300 | +6.4% | 0.79% | +5.9% |
| Q3 2014 | $4,022,000 | -17.2% | 581,992 | -0.1% | 0.75% | -8.8% |
| Q2 2014 | $4,858,000 | +43.1% | 582,492 | +19.8% | 0.82% | +51.0% |
| Q1 2014 | $3,394,000 | +53.8% | 486,300 | +63.0% | 0.54% | +48.8% |
| Q4 2013 | $2,207,000 | -15.7% | 298,300 | 0.0% | 0.36% | -28.6% |
| Q3 2013 | $2,619,000 | -54.4% | 298,300 | -14.4% | 0.51% | -60.4% |
| Q2 2013 | $5,747,000 | – | 348,300 | – | 1.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coliseum Capital Management, LLC | 5,622,410 | $5,847,000 | 2.64% |
| NORTH TIDE CAPITAL, LLC | 8,500,000 | $8,840,000 | 1.51% |
| WYNNEFIELD CAPITAL INC | 3,700,000 | $3,848,000 | 1.39% |
| Alta Fundamental Advisers LLC | 2,330,774 | $2,424,000 | 1.20% |
| ARDSLEY ADVISORY PARTNERS LP | 6,350,000 | $6,604,000 | 1.09% |
| Camber Capital Management LP | 10,180,000 | $10,587,000 | 0.55% |
| PERKINS CAPITAL MANAGEMENT INC | 298,000 | $310,000 | 0.34% |
| Hawk Ridge Capital Management | 340,429 | $354,000 | 0.18% |
| Eidelman Virant Capital | 220,000 | $228,000 | 0.13% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 227,280 | $236,000 | 0.11% |